Connie J. Standiford, MD

Articles by Connie J. Standiford, MD

New Diabetes HEDIS Blood Pressure Quality Measure: Potential for Overtreatment

ByHae Mi Choe, PharmD,Steven J. Bernstein, MD, MPH,Connie J. Standiford, MD,Rodney A. Hayward, MD

January 14th 2010

The new HEDIS diabetes blood pressure measure may promote performance incentives for overtreatment of blood pressure, causing potential harm, especially in the elderly population.

Moving From A to Z: Successful Implementation of a Statin Switch Program by a Large Physician Group

ByFangyan Z. Sy, PharmD,Hae Mi Choe, PharmD,Diane M. Kennedy, BS,Connie J. Standiford, MD,Dawn M. Parsons, RPh, MBA,Keith D. Bruhnsen, MSW,James G. Stevenson, PharmD,Steven J. Bernstein, MD

April 2nd 2009

This report shows that a successful, cost-effective statin switch program can be implemented by a large physician group via a centralized, collaborative process.

Impact of Patient Financial Incentives on Participation and Outcomes in a Statin Pill-splitting Program

ByHae Mi Choe, PharmD,James G. Stevenson, PharmD,Daniel S. Streetman, PharmD,Michele Heisler, MD, MPA,Connie J. Standiford, MD,John D. Piette, PhD

June 1st 2007

Connie J. Standiford, MD

Articles by Connie J. Standiford, MD

New Diabetes HEDIS Blood Pressure Quality Measure: Potential for Overtreatment

Moving From A to Z: Successful Implementation of a Statin Switch Program by a Large Physician Group

Impact of Patient Financial Incentives on Participation and Outcomes in a Statin Pill-splitting Program

Latest Updated Articles

Trending on AJMC

FDA Approves Enlicitide, First Oral PCSK9 for High Cholesterol

Home-Based Heart Failure Care Shows Comparable Safety to Continued Inpatient Care

Cardiology Prices Vary Widely by Insurer and State

Voice Biomarkers Show Promise for Asthma, COPD Exacerbation Detection

Rethinking Cardiometabolic Risk: Deepak Bhatt, MD, MPH, MBA